Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1,800,000 Profiles
More than 3,500 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Johann Wojta

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Physiology

Procedures

Enzyme-Linked Immunosorbent Assay

Concepts & Ideas

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Rychli Kathrin; Huber Kurt; Wojta Johann
Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease.
Kastl Stefan P; Speidl Walter S; Katsaros Katharina M; Kaun Christoph; Rega Gersina; Assadian Afshin; Hagmueller Georg W; Hoeth Martina; de Martin Rainer; Ma Yongsheng; Maurer Gerald; Huber Kurt; Wojta Johann
Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation.
Hanusch-Enserer Ursula; Zorn Gerlinde; Wojta Johann; Kopp Christoph W; Prager Rudolf; Koenig Wolfgang; Schillinger Martin; Roden Michael; Huber Kurt
Non-conventional markers of atherosclerosis before and after gastric banding surgery.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Johann Wojta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Rychli Kathrin; Huber Kurt; Wojta Johann
Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease.
Expert opinion on therapeutic targets 2009;13(11):1295-302.
2009: Kastl Stefan P; Speidl Walter S; Katsaros Katharina M; Kaun Christoph; Rega Gersina; Assadian Afshin; Hagmueller Georg W; Hoeth Martina; de Martin Rainer; Ma Yongsheng; Maurer Gerald; Huber Kurt; Wojta Johann
Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation.
Blood 2009;114(13):2812-8.
2009: Hanusch-Enserer Ursula; Zorn Gerlinde; Wojta Johann; Kopp Christoph W; Prager Rudolf; Koenig Wolfgang; Schillinger Martin; Roden Michael; Huber Kurt
Non-conventional markers of atherosclerosis before and after gastric banding surgery.
European heart journal 2009;30(12):1516-24.
2009: Niessner Alexander; Hohensinner Philipp J; Rychli Kathrin; Neuhold Stephanie; Zorn Gerlinde; Richter Bernhard; Hülsmann Martin; Berger Rudolf; Mörtl Deddo; Huber Kurt; Wojta Johann; Pacher Richard
Prognostic value of apoptosis markers in advanced heart failure patients.
European heart journal 2009;30(7):789-96.
2008: Gyöngyösi Mariann; Blanco Jeronimo; Marian Teréz; Trón Lajos; Petneházy Ors; Petrasi Zsolt; Hemetsberger Rayyan; Rodriguez Julio; Font Gusztáv; Pavo Imre J; Kertész István; Balkay László; Pavo Noemi; Posa Aniko; Emri Miklos; Galuska László; Kraitchman Dara L; Wojta Johann; Huber Kurt; Glogar Dietmar
Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression.
Circulation. Cardiovascular imaging 2008;1(2):94-103.
2008: Wexberg Paul; Jordanova Nelli; Strehblow Christoph; Syeda Bonni; Meyer Brigitte; Charvat Silvia; Zorn Gerlinde; Scheinig Daniela; Wojta Johann; Huber Kurt; Glogar Dietmar; Gyöngyösi Mariann
Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.
Thrombosis and haemostasis 2008;99(4):739-48.
2008: Kern Johann; Bauer Monika; Rychli Kathrin; Wojta Johann; Ritsch Andreas; Gastl Günther; Gunsilius Eberhard; Untergasser Gerold
Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(3):478-84.
2008: Kastl Stefan P; Speidl Walter S; Kaun Christoph; Katsaros Katharina M; Rega Gersina; Afonyushkin Taras; Bochkov Valery N; Valent Peter; Assadian Afshin; Hagmueller Georg W; Hoeth Martina; de Martin Rainer; Ma Yongsheng; Maurer Gerald; Huber Kurt; Wojta Johann
In human macrophages the complement component C5a induces the expression of oncostatin M via AP-1 activation.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(3):498-503.
2008: Katsaros K M; Speidl W S; Kastl S P; Zorn G; Huber K; Maurer G; Glogar D; Wojta J; Christ G
Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents.
Journal of thrombosis and haemostasis : JTH 2008;6(3):508-13.
2008: Katsaros Katharina M; Kastl Stefan P; Huber Kurt; Zorn Gerlinde; Maurer Gerald; Glogar Dietmar; Wojta Johann; Christ Günter; Speidl Walter S
Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.
Thrombosis research 2008;123(1):79-84.
2007: Hohensinner P J; Kaun C; Rychli K; Niessner A; Pfaffenberger S; Rega G; de Martin R; Maurer G; Ullrich R; Huber K; Wojta J
Macrophage colony stimulating factor expression in human cardiac cells is upregulated by tumor necrosis factor-alpha via an NF-kappaB dependent mechanism.
Journal of thrombosis and haemostasis : JTH 2007;5(12):2520-8.
2007: Mildner Michael; Mlitz Veronika; Gruber Florian; Wojta Johann; Tschachler Erwin
Hepatocyte growth factor establishes autocrine and paracrine feedback loops for the protection of skin cells after UV irradiation.
The Journal of investigative dermatology 2007;127(11):2637-44.
2007: Demyanets Svitlana; Kaun Christoph; Rychli Kathrin; Rega Gersina; Pfaffenberger Stefan; Afonyushkin Taras; Bochkov Valery N; Maurer Gerald; Huber Kurt; Wojta Johann
The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
American journal of physiology. Heart and circulatory physiology 2007;293(3):H1962-8.
2007: Höchtl Thomas; Pachinger Linda; Unger Gerhard; Geppert Alexander; Wojta Johann; Harenberg Job; Huber Kurt
Antiplatelet drug induced isolated profound thrombocytopenia in interventional cardiology: a review based on individual case reports.
Journal of thrombosis and thrombolysis 2007;24(1):59-64.
2007: Rega G; Kaun C; Demyanets S; Pfaffenberger S; Rychli K; Hohensinner P J; Kastl S P; Speidl W S; Weiss T W; Breuss J M; Furnkranz A; Uhrin P; Zaujec J; Zilberfarb V; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(7):1587-95.
2007: Siller-Matula Jolanta; Schrör Karsten; Wojta Johann; Huber Kurt
Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
Thrombosis and haemostasis 2007;97(3):385-93.
2007: Speidl Walter Stefan; Nikfardjam Mariam; Niessner Alexander; Jordanova Nelli; Zorn Gerlinde; Maurer Gerald; Schreiber Wolfgang; Wojta Johann; Huber Kurt
Premature compared with late onset of coronary artery disease: young patients show a severe defect in fibrinolytic response to venous occlusion.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(2):165-71.
2007: Speidl Walter S; Exner Markus; Amighi Jasmin; Mlekusch Wolfgang; Sabeti Schila; Kastl Stefan P; Zorn Gerlinde; Maurer Gerald; Wagner Oswald; Huber Kurt; Minar Erich; Wojta Johann; Schillinger Martin
Complement component C5a predicts restenosis after superficial femoral artery balloon angioplasty.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2007;14(1):62-9.
2007: Ben-Tal Cohen E; Hohensinner P J; Kaun C; Maurer G; Huber K; Wojta J
Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro.
Biochemical pharmacology 2007;73(1):77-83.
2007: Jarai Rudolf; Iordanova Nelly; Jarai Robert; Jarai Ferenc; Raffetseder Annamaria; Woloszczuk Wolfgang; Gyöngyösi Mariann; Geyer Georg; Wojta Johann; Huber Kurt
Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels.
Wiener klinische Wochenschrift 2007;119(21-22):626-32.
2007: Speidl Walter Stefan; Nikfardjam Mariam; Niessner Alexander; Zeiner Andrea; Jordanova Nelli; Zorn Gerlinde; Maurer Gerald; Schreiber Wolfgang; Wojta Johann; Huber Kurt
Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
Thrombosis research 2007;119(3):331-6.
2006: Niessner Alexander; Steiner Sabine; Speidl Walter S; Pleiner Johannes; Seidinger Daniela; Maurer Gerald; Goronzy Jörg J; Weyand Cornelia M; Kopp Christoph W; Huber Kurt; Wolzt Michael; Wojta Johann
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo.
Atherosclerosis 2006;189(2):408-13.
2006: Weiss T W; Kvakan H; Kaun C; Prager M; Speidl W S; Zorn G; Pfaffenberger S; Huk I; Maurer G; Huber K; Wojta J
No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis.
Journal of clinical pathology 2006;59(11):1186-90.
2006: Bochkov Valery N; Philippova Maria; Oskolkova Olga; Kadl Alexandra; Furnkranz Alexander; Karabeg Erduan; Afonyushkin Taras; Gruber Florian; Breuss Johannes; Minchenko Alexander; Mechtcheriakova Diana; Hohensinner Philipp; Rychli Kathrin; Wojta Johann; Resink Therese; Erne Paul; Binder Bernd R; Leitinger Norbert
Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions.
Circulation research 2006;99(8):900-8.
2006: Gyöngyösi Mariann; Strehblow Christoph; Sperker Wolfgang; Hevesi Akos; Garamvölgyi Rita; Petrási Zsolt; Pavo Noemi; Ferdinandy Péter; Csonka Csaba; Csont Tamås; Sylvèn Christer; Declerck Paul J; Pavo Imre; Wojta Johann; Glogar Dietmar; Huber Kurt
Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours.
Thrombosis and haemostasis 2006;96(2):202-9.
2006: Kastl S P; Speidl W S; Kaun C; Rega G; Assadian A; Weiss T W; Valent P; Hagmueller G W; Maurer G; Huber K; Wojta J
The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation.
Journal of thrombosis and haemostasis : JTH 2006;4(8):1790-7.
2006: Hohensinner Philipp J; Kaun Christoph; Rychli Kathrin; Ben-Tal Cohen Enbal; Kastl Stefan P; Demyanets Svitlana; Pfaffenberger Stefan; Speidl Walter S; Rega Gersina; Ullrich Robert; Maurer Gerald; Huber Kurt; Wojta Johann
Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxia.
FEBS letters 2006;580(14):3532-8.
2006: Niessner Alexander; Richter Bernhard; Penka Martina; Steiner Sabine; Strasser Barbara; Ziegler Sophie; Heeb-Elze Elke; Zorn Gerlinde; Leitner-Heinschink Angelika; Niessner Christina; Wojta Johann; Huber Kurt
Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque stabilization?
Atherosclerosis 2006;186(1):160-5.
2006: Demyanets Svitlana; Kaun Christoph; Pfaffenberger Stefan; Hohensinner Philipp J; Rega Gersina; Pammer Johannes; Maurer Gerald; Huber Kurt; Wojta Johann
Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Biochemical pharmacology 2006;71(9):1324-30.
2006: Demyanets S; Kaun C; Maurer G; Huber K; Wojta J
Statins modulate expression of components of the plasminogen activator/plasmin system in human cardiac myocytes in vitro.
Journal of thrombosis and haemostasis : JTH 2006;4(2):476-9.
2006: Demyanets Svitlana; Pfaffenberger Stefan; Kaun Christoph; Rega Gersina; Speidl Walter S; Kastl Stefan P; Weiss Thomas W; Hohensinner Philipp J; Dietrich Wolf; Tschugguel Walter; Bochkov Valery N; Awad Ezzat M; Maurer Gerald; Huber Kurt; Wojta Johann
The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway.
Thrombosis and haemostasis 2006;95(1):107-16.
2005: Höchtl Thomas; Geppert Alexander; Nürnberg Michael; Unger Gerhard; Speidl Walter; Wojta Johann; Huber Kurt
[Direct and indirect antithrombins in acute coronary syndromes]
Wiener klinische Wochenschrift 2005;117(23-24):792-800.
2005: Richter Bernhard; Niessner Alexander; Penka Martina; Grdic Marija; Steiner Sabine; Strasser Barbara; Ziegler Sophie; Zorn Gerlinde; Maurer Gerald; Simeon-Rudolf Vera; Wojta Johann; Huber Kurt
Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events.
Thrombosis and haemostasis 2005;94(6):1306-11.
2005: Niessner Alexander; Marculescu Rodrig; Kvakan Heda; Haschemi Arvand; Endler Georg; Weyand Cornelia M; Maurer Gerald; Mannhalter Christine; Wojta Johann; Wagner Oswald; Huber Kurt
Fractalkine receptor polymorphisms V2491 and T280M as genetic risk factors for restenosis.
Thrombosis and haemostasis 2005;94(6):1251-6.
2005: Jarai Rudolf; Wojta Johann; Huber Kurt
Circulating B-type natriuretic peptides in patients with acute coronary syndromes. Pathophysiological, prognostical and therapeutical considerations.
Thrombosis and haemostasis 2005;94(5):926-32.
2005: Speidl Walter S; Exner Markus; Amighi Jasmin; Kastl Stefan P; Zorn Gerlinde; Maurer Gerald; Wagner Oswald; Huber Kurt; Minar Erich; Wojta Johann; Schillinger Martin
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis.
European heart journal 2005;26(21):2294-9.
2005: Gulesserian Talin; Wenzel Catharina; Endler Georg; Sunder-Plassmann Raute; Marsik Claudia; Mannhalter Christine; Iordanova Nelly; Gyöngyösi Mariann; Wojta Johann; Mustafa Stefan; Wagner Oswald; Huber Kurt
Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant.
Clinical chemistry 2005;51(9):1661-5.
2005: Weiss T W; Kvakan H; Kaun C; Zorn G; Speidl W S; Pfaffenberger S; Maurer G; Huber K; Wojta J
The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart.
Journal of molecular and cellular cardiology 2005;39(3):545-51.
2005: Steiner Sabine; Niessner Alexander; Ziegler Sophie; Richter Bernhard; Seidinger Daniela; Pleiner Johannes; Penka Martina; Wolzt Michael; Huber Kurt; Wojta Johann; Minar Erich; Kopp Christoph W
Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease.
Atherosclerosis 2005;181(2):305-10.
2005: Pfaffenberger Stefan; Devcic-Kuhar Branka; Kastl Stefan P; Huber Kurt; Maurer Gerald; Wojta Johann; Gottsauner-Wolf Michael
Ultrasound thrombolysis.
Thrombosis and haemostasis 2005;94(1):26-36.
2005: Pfaffenberger Stefan; Wojta Johann; Gottsauner-Wolf Michael
High-frequency transtemporal sonothrombolysis.
Stroke; a journal of cerebral circulation 2005;36(7):1356-7.
2005: Niessner Alexander; Marculescu Rodrig; Haschemi Arvand; Endler Georg; Zorn Gerlinde; Weyand Cornelia M; Maurer Gerald; Mannhalter Christine; Wojta Johann; Wagner Oswald; Huber Kurt
Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Thrombosis and haemostasis 2005;93(5):949-54.
2005: Rega G; Kaun C; Weiss T W; Demyanets S; Zorn G; Kastl S P; Steiner S; Seidinger D; Kopp C W; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
Circulation 2005;111(15):1938-45.
2005: Steiner Sabine; Speidl Walter S; Pleiner Johannes; Seidinger Daniela; Zorn Gerlinde; Kaun Christoph; Wojta Johann; Huber Kurt; Minar Erich; Wolzt Michael; Kopp Christoph W
Simvastatin blunts endotoxin-induced tissue factor in vivo.
Circulation 2005;111(14):1841-6.
2005: Jordanova Nelly; Gyöngyösi Mariann; Khorsand Aliasghar; Falkensammer Christine; Zorn Gerlinde; Wojta Johann; Anvari Anahit; Huber Kurt
New cut-off values of cardiac markers for risk stratification of angina pectoris.
International journal of cardiology 2005;99(3):429-35.
2005: Niessner Alexander; Graf Senta; Nikfardjam Mariam; Lehr Stephan; Maurer Gerald; Wojta Johann; Huber Kurt
The adaptive immune system and long-term outcome in patients with stable coronary disease. Predictive value of routine laboratory measurements.
Thrombosis and haemostasis 2005;93(2):257-60.
2005: Christ G; Nikfardjam M; Huber-Beckmann R; Gottsauner-Wolf M; Glogar D; Binder B R; Wojta J; Huber K
Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
Journal of thrombosis and haemostasis : JTH 2005;3(2):233-9.
2005: Jarai Rudolf; Iordanova Nelly; Jarai Robert; Raffetseder Annamaria; Woloszczuk Wolfgang; Gyöngyösi Mariann; Geyer Georg; Wojta Johann; Huber Kurt
Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
European heart journal 2005;26(3):250-6.
2005: Speidl Walter Stefan; Zeiner Andrea; Nikfardjam Mariam; Geppert Alexander; Jordanova Nelli; Niessner Alexander; Zorn Gerlinde; Maurer Gerald; Schreiber Wolfgang; Wojta Johann; Huber Kurt
An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
Journal of the American College of Cardiology 2005;45(1):30-4.
2005: Pfaffenberger Stefan; Devcic-Kuhar Branka; Kollmann Christian; Kastl Stefan P; Kaun Christoph; Speidl Walter S; Weiss Thomas W; Demyanets Svitlana; Ullrich Robert; Sochor Heinz; Wöber Christian; Zeitlhofer Josef; Huber Kurt; Gröschl Martin; Benes Ewald; Maurer Gerald; Wojta Johann; Gottsauner-Wolf Michael
Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model.
Stroke; a journal of cerebral circulation 2005;36(1):124-8.
2004: Uchiba Mitsuhiro; Okajima Kenji; Kaun Christoph; Wojta Johann; Binder Bernd R
Inhibition of the endothelial cell activation by antithrombin in vitro.
Thrombosis and haemostasis 2004;92(6):1420-7.
2004: Gyöngyösi Mariann; Domanovits Hans; Benzer Werner; Haugk Moritz; Heinisch Birgit; Sodeck Gottfried; Hödl Ronald; Gaul Georg; Bonner Gerhard; Wojta Johann; Laggner Anton; Glogar Dietmar; Huber Kurt;
Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.
European heart journal 2004;25(23):2125-33.
2004: Funk Marion; Endler Georg; Freitag Renate; Wojta Johann; Huber Kurt; Mannhalter Christine; Sunder-Plassmann Raute
CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarction.
Clinical chemistry 2004;50(12):2395-8.
2004: Devcic-Kuhar Branka; Pfaffenberger Stefan; Gherardini Lisa; Mayer Christoph; Gröschl Martin; Kaun Christoph; Benes Ewald; Tschachler Erwin; Huber Kurt; Maurer Gerald; Wojta Johann; Gottsauner-Wolf Michael
Ultrasound affects distribution of plasminogen and tissue-type plasminogen activator in whole blood clots in vitro.
Thrombosis and haemostasis 2004;92(5):980-5.
2004: Niessner Alexander; Hornykewycz Stephan; Graf Senta; Nikfardjam Mariam; Speidl Walter S; Probst Peter; Zorn Gerlinde; Maurer Gerald; Wojta Johann; Huber Kurt
Pre-existing anticardiolipin antibodies and development of restenosis after coronary balloon angioplasty: predictive value for a complicated course?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(4):311-6.
2004: Pammer J; Reinisch C; Kaun C; Tschachler E; Wojta J
Inhibitors of differentiation/DNA binding proteins Id1 and Id3 are regulated by statins in endothelial cells.
Endothelium : journal of endothelial cell research 2004;11(3-4):175-80.
2004: Weiss Thomas Werner; Mehrabi Mohammad Reza; Kaun Christoph; Zorn Gerlinde; Kastl Stefan Peter; Speidl Walter Stefan; Pfaffenberger Stefan; Rega Gersina; Glogar Helmut Dietmar; Maurer Gerald; Pacher Richard; Huber Kurt; Wojta Johann
Prostaglandin E1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanism.
Journal of molecular and cellular cardiology 2004;36(4):539-46.
2004: Speidl Walter S; Toller Wolfgang G; Kaun Christoph; Weiss Thomas W; Pfaffenberger Stefan; Kastl Stefan P; Furnkranz Alexander; Maurer Gerald; Huber Kurt; Metzler Helfried; Wojta Johann
Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(3):603-5.
2004: Kopp Christoph W; Hölzenbein Thomas; Steiner Sabine; Marculescu Rodrig; Bergmeister Helga; Seidinger Daniela; Mosberger Isabella; Kaun Christoph; Cejna Manfred; Horvat Reinhard; Wojta Johann; Maurer Gerald; Binder Bernd R; Breuss Johannes M; Ecker Rupert C; de Martin Rainer; Minar Erich
Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity.
Blood 2004;103(5):1653-61.
2004: Endler Georg; Exner Markus; Schillinger Martin; Marculescu Rodrig; Sunder-Plassmann Raute; Raith Marianne; Jordanova Nelli; Wojta Johann; Mannhalter Christine; Wagner Oswald F; Huber Kurt
A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease.
Thrombosis and haemostasis 2004;91(1):155-61.
2004: Gyöngyösi Mariann; Glogar Dietmar; Weidinger Franz; Domanovits Hans; Laggner Anton; Wojta Johann; Zorn Gerlinde; Iordanova Nelli; Huber Kurt
Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
American heart journal 2004;147(1):158-64.
2003: Zhang Wei-Jian; Hufnagl Peter; Binder Bernd R; Wojta Johann
Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression.
Thrombosis and haemostasis 2003;90(5):904-14.
2003: Gallicchio Marisa A; Kaun Christoph; Wojta Johann; Binder Bernd; Bach Leon A
Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Journal of cellular physiology 2003;197(1):131-8.
2003: Wojta Johann; Huber Kurt; Valent Peter
New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):438-41.
2003: Weiss Thomas W; Speidl Walter S; Kaun Christoph; Rega Gersina; Springer Christopher; Macfelda Karin; Losert Udo M; Grant Susan L; Marro Martin L; Rhodes Andrew D; Fuernkranz Alexander; Bialy Jan; Ullrich Robert; Holzmann Philipp; Pacher Richard; Maurer Gerald; Huber Kurt; Wojta Johann
Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes.
Cardiovascular research 2003;59(3):628-38.
2003: Schäfer Romana; Abraham Dietmar; Paulus Patrick; Blumer Roland; Grimm Michael; Wojta Johann; Aharinejad Seyedhossein
Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
Circulation 2003;108(13):1585-91.
2003: Niessner Alexander; Graf Senta; Nikfardjam Mariam; Speidl Walter S; Huber-Beckmann Renate; Zorn Gerlinde; Wojta Johann; Huber Kurt
Circulating t-PA antigen predicts major adverse coronary events in patients with stable coronary artery disease--a 13-year follow-up.
Thrombosis and haemostasis 2003;90(2):344-50.
2003: Niessner Alexander; Kaun Christoph; Zorn Gerlinde; Speidl Walter; Türel Zeynep; Christiansen Gunna; Pedersen Anna-Sofie; Birkelund Svend; Simon Susan; Georgopoulos Apostolos; Graninger Wolfgang; de Martin Rainer; Lipp Joachim; Binder Bernd R; Maurer Gerald; Huber Kurt; Wojta Johann
Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway.
The Journal of infectious diseases 2003;188(1):108-13.
2003: Endler Georg; Hamwi Ahmad; Sunder-Plassmann Raute; Exner Markus; Vukovich Thomas; Mannhalter Christine; Wojta Johann; Huber Kurt; Wagner Oswald
Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women?
Clinical chemistry 2003;49(7):1201-4.
2003: Uchiba Mitsuhiro; Okajima Kenji; Kaun Christoph; Binder Bernd R; Wojta Johann
Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro.
Critical care medicine 2003;31(4):1147-53.
2003: Pfaffenberger Stefan; Devcic-Kuhar Branka; El-Rabadi Karem; Gröschl Martin; Speidl Walter S; Weiss Thomas W; Huber Kurt; Benes Ewald; Maurer Gerald; Wojta Johann; Gottsauner-Wolf Michael
2MHz ultrasound enhances t-PA-mediated thrombolysis: comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves.
Thrombosis and haemostasis 2003;89(3):583-9.
2003: Endler Georg; Exner Markus; Raith Marianne; Marculescu Rodrig; Mannhalter Christine; Endler Lukas; Wojta Johann; Huber Kurt; Wagner Oswald F
The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2.
Thrombosis research 2003;112(1-2):47-50.
2003: Weltermann Ansgar; Fritsch Peter; Kyrle Paul A; Schoenauer Verena; Heinze Georg; Wojta Johann; Christ Günter; Huber Kurt
Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting.
Thrombosis research 2003;112(1-2):19-24.
2002: Macfelda Karin; Weiss Thomas W; Kaun Christoph; Breuss Johannes M; Zorn Gerlinde; Oberndorfer Ulrich; Voegele-Kadletz Margit; Huber-Beckmann Renate; Ullrich Robert; Binder Bernd R; Losert Udo M; Maurer Gerald; Pacher Richard; Huber Kurt; Wojta Johann
Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes.
Journal of molecular and cellular cardiology 2002;34(12):1681-91.
2002: Prager Manfred; Türel Zeynep; Speidl Walter S; Zorn Gerlinde; Kaun Christoph; Niessner Alexander; Heinze Georg; Huk Igor; Maurer Gerald; Huber Kurt; Wojta Johann
Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals.
Stroke; a journal of cerebral circulation 2002;33(12):2756-61.
2002: Mehrabi Mohammad Reza; Serbecic Nermin; Tamaddon Forouzan; Kaun Christoph; Huber Kurt; Pacher Richard; Wild Thomas; Mall Gerhard; Wojta Johann; Glogar Helmut-D
Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease.
Cardiovascular research 2002;56(2):214-24.
2002: Mehrabi Mohammad Reza; Huber Kurt; Serbecic Nermin; Wild Thomas; Wojta Johann; Tamaddon Forouzan; Morgan Abdelmonem; Ullrich Robert; Dietmar Glogar Helmut
Elevated homocysteine serum level is associated with low enrichment of homocysteine in coronary arteries of patients with coronary artery disease.
Thrombosis research 2002;107(5):189-96.
2002: Speidl Walter S; Graf Senta; Hornykewycz Stefan; Nikfardjam Mariam; Niessner Alexander; Zorn Gerlinde; Wojta Johann; Huber Kurt
High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease.
American heart journal 2002;144(3):449-55.
2002: Wojta Johann; Kaun Christoph; Zorn Gerlinde; Ghannadan Minoo; Hauswirth Alexander W; Sperr Wolfgang R; Fritsch Gerhard; Printz Dieter; Binder Bernd R; Schatzl Georg; Zwirner Joerg; Maurer Gerald; Huber Kurt; Valent Peter
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils.
Blood 2002;100(2):517-23.
2002: Valent P; Baghestanian M; Bankl H C; Sillaber C; Sperr W R; Wojta J; Binder B R; Lechner K
New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells.
Thrombosis and haemostasis 2002;87(5):786-90.
2002: Wiesbauer Franz; Kaun Christoph; Zorn Gerlinde; Maurer Gerald; Huber Kurt; Wojta Johann
HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
British journal of pharmacology 2002;135(1):284-92.
2001: Nikfardjam M; Graf S; Hornykewycz S; Zorn G; Huber-Beckmann R; Wojta J; Huber K
Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease.
Thrombosis research 2001;103 Suppl 1():S35-9.
2001: Huber K; Christ G; Wojta J; Gulba D
Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001.
Thrombosis research 2001;103 Suppl 1():S7-19.
2001: Anvari A; Schuster E; Gottsauner-Wolf M; Wojta J; Huber K
PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease.
Thrombosis research 2001;103(2):103-7.
2001: Ruan Q R; Zhang W J; Hufnagl P; Kaun C; Binder B R; Wojta J
Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
Journal of vascular research 2001;38(1):13-9.
2000: Roller R E; Janisch S; Kvas E; Schnedl W J; Binder B R; Wojta J; Korninger C
Smooth muscle cell migration promoting activity of plasma predicts restenosis in patients with peripheral arterial occlusive disease undergoing angioplasty.
Thrombosis and haemostasis 2000;84(6):1113-6.
2000: Gottsauner-Wolf M; Wexberg P; el-Rabadi K; Wojta J; Maurer G; Huber K
[Atherosclerosis: an infectious disease?]
Wiener klinische Wochenschrift 2000;112(6):253-9.
1999: Pammer J; Weninger W; Ban J; Wojta J; Tschachler E
The cell death regulatory protein bak is expressed in endothelial cells in inflamed tissues and Is induced by IFN-gamma in vitro.
Biochemical and biophysical research communications 1999;264(1):139-43.
1999: Obermair A; Obruca A; Pöhl M; Kaider A; Vales A; Leodolter S; Wojta J; Feichtinger W
Vascular endothelial growth factor and its receptors in male fertility.
Fertility and sterility 1999;72(2):269-75.
1999: Krebs M; Uhrin P; Vales A; Prendes-Garcia M J; Wojta J; Geiger M; Binder B R
Protein C inhibitor is expressed in keratinocytes of human skin.
The Journal of investigative dermatology 1999;113(1):32-7.
1999: Roller R E; Janisch S; Carroll V; Kvas E; Pilger E; Binder B R; Wojta J
Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty.
Thrombosis research 1999;94(4):241-7.
1999: Wojta J; Kaun C; Breuss J M; Koshelnick Y; Beckmann R; Hattey E; Mildner M; Weninger W; Nakamura T; Tschachler E; Binder B R
Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
Laboratory investigation; a journal of technical methods and pathology 1999;79(4):427-38.
1999: Zhang J C; Ruan Q; Paucz L; Fabry A; Binder B R; Wojta J
Stimulation of tissue factor expression in human microvascular and macrovascular endothelial cells by cultured vascular smooth muscle cells in vitro.
Journal of vascular research 1999;36(2):126-32.
1998: Pammer J; Weninger W; Mildner M; Burian M; Wojta J; Tschachler E
Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals.
The Journal of pathology 1998;186(2):186-91.
1997: Tschugguel W; Zhegu Z; Schneeberger C; Tantscher E; Czerwenka K; Fabry A; Wojta J; Zeillinger R; Huber J C
Estrogen does not induce the calcium-dependent nitric oxide synthase in cultured human uterine endothelial and myometrial smooth muscle cells.
Journal of vascular research 1997;34(4):281-8.
1997: Zhang W J; Wojta J; Binder B R
Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.
Journal of vascular research 1997;34(4):273-80.
1997: Zhang W J; Wojta J; Binder B R
Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary artery.
Cellular and molecular biology (Noisy-le-Grand, France) 1997;43(4):581-7.
1997: Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder B R
Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(4):723-30.
1997: Zhang W J; Wojta J; Binder B R
Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivo.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(3):465-74.
1997: Baghestanian M; Hofbauer R; Kress H G; Wojta J; Fabry A; Binder B R; Kaun C; Müller M R; Mehrabi M R; Kapiotis S; Sengoelge G; Ghannadan M; Lechner K; Valent P
Thrombin augments vascular cell-dependent migration of human mast cells: role of MGF.
Thrombosis and haemostasis 1997;77(3):577-84.
1996: Zhang J C; Fabry A; Paucz L; Wojta J; Binder B R
Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cells.
Blood 1996;88(10):3880-6.
1996: Zoellner H; Höfler M; Beckmann R; Hufnagl P; Vanyek E; Bielek E; Wojta J; Fabry A; Lockie S; Binder B R
Serum albumin is a specific inhibitor of apoptosis in human endothelial cells.
Journal of cell science 1996;109 ( Pt 10)():2571-80.
1996: Gallicchio M; Hufnagl P; Wojta J; Tipping P
IFN-gamma inhibits thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in human endothelial cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(6):2610-7.
1995: Zhang J C; Wojta J; Binder B R
Growth and fibrinolytic parameters of human umbilical vein endothelial cells seeded onto cardiovascular grafts.
The Journal of thoracic and cardiovascular surgery 1995;109(6):1059-65.
1994: al-Azhary D B; Wojta J; Binder B R
Fibrinolytic system of cultured rabbit aortic endothelial cells.
Thrombosis research 1994;75(5):559-68.
1994: Campbell I K; Wojta J; Novak U; Hamilton J A
Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor-B basic fibroblast growth factor.
Biochimica et biophysica acta 1994;1226(3):277-85.
1994: Zhang W; Wojta J; Binder B R
Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(7):1040-6.
1994: Wojta J; Nakamura T; Fabry A; Hufnagl P; Beckmann R; McGrath K; Binder B R
Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells.
Blood 1994;84(1):151-7.
1994: Gallicchio M; Argyriou S; Ianches G; Filonzi E L; Zoellner H; Hamilton J A; McGrath K; Wojta J
Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(5):815-23.
1994: Wojta J; Zoellner H; Gallicchio M; Filonzi E L; Hamilton J A; McGrath K
Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro.
Lymphokine and cytokine research 1994;13(2):133-8.
1994: Liu J J; Casley D; Wojta J; Gallicchio M; Dauer R; Johnston C I; Buxton B F
Effects of calcium- and ETA-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human internal mammary artery.
Clinical and experimental pharmacology & physiology 1994;21(1):49-57.
1993: Hamilton J A; Whitty G A; Stanton H; Wojta J; Gallichio M; McGrath K; Ianches G
Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes.
Blood 1993;82(12):3616-21.
1993: Hamilton J A; Whitty G A; Wojta J; Gallichio M; McGrath K; Ianches G
Regulation of plasminogen activator inhibitor-1 levels in human monocytes.
Cellular immunology 1993;152(1):7-17.
1993: Hamilton J A; Wojta J; Gallichio M; McGrath K; Filonzi E L
Contrasting effects of transforming growth factor-beta and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(10):5154-61.
1993: Wojta J; Gallicchio M; Zoellner H; Hufnagl P; Last K; Filonzi E L; Binder B R; Hamilton J A; McGrath K
Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
Thrombosis and haemostasis 1993;70(3):469-74.
1993: Liu J J; Casley D; Wojta J; Gallicchio M; Dauer R; Buxton B F; Johnston C I
Reduction of endothelin levels by the dihydropyridine calcium antagonist nisoldipine and a 'natural factor' in cultured human endothelial cells.
Journal of hypertension 1993;11(9):977-82.
1993: Wojta J; Gallicchio M; Zoellner H; Filonzi E L; Hamilton J A; McGrath K
Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells.
Blood 1993;81(12):3285-92.
1993: Christ G; Seiffert D; Hufnagl P; Gessl A; Wojta J; Binder B R
Type 1 plasminogen activator inhibitor synthesis of endothelial cells is downregulated by smooth muscle cells.
Blood 1993;81(5):1277-83.
1993: Zoellner H; Wojta J; Gallicchio M; McGrath K; Hamilton J A
Cytokine regulation of the synthesis of plasminogen activator inhibitor-2 by human vascular endothelial cells. Comparison with plasminogen activator inhibitor-1 synthesis.
Thrombosis and haemostasis 1993;69(2):135-40.
1992: Hamilton J A; Cheung D; Filonzi E L; Piccoli D S; Wojta J; Gallichio M; McGrath K; Last K
Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts.
Arthritis and rheumatism 1992;35(12):1526-34.
1992: Hamilton J A; Campbell I K; Wojta J; Cheung D
Plasminogen activators and their inhibitors in arthritic disease.
Annals of the New York Academy of Sciences 1992;667():87-100.
1992: Wojta J; Zoellner H; Gallicchio M; Hamilton J A; McGrath K
Gamma-interferon counteracts interleukin-1 alpha stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro.
Biochemical and biophysical research communications 1992;188(1):463-9.
1992: Wagner O F; Christ G; Wojta J; Vierhapper H; Parzer S; Nowotny P J; Schneider B; Waldhäusl W; Binder B R
Polar secretion of endothelin-1 by cultured endothelial cells.
The Journal of biological chemistry 1992;267(23):16066-8.
1989: Geiger M; Huber K; Wojta J; Stingl L; Espana F; Griffin J H; Binder B R
Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo.
Blood 1989;74(2):722-8.
1989: Kirchheimer J C; Wojta J; Christ G; Binder B R
Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(14):5424-8.
1989: Wojta J; Beckmann R; Turcu L; Wagner O F; van Zonneveld A J; Binder B R
Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
The Journal of biological chemistry 1989;264(14):7957-61.
1988: Huber K; Wojta J; Kirchheimer J C; Ermler D; Binder B R
Plasminogen activators and plasminogen activator inhibitor in malignant and non-malignant ascitic fluid.
European journal of clinical investigation 1988;18(6):595-9.
1988: Kirchheimer J C; Wojta J; Christ G; Hienert G; Binder B R
Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cells.
Carcinogenesis 1988;9(11):2121-3.
1988: Bartha K; Wojta J; Wagner O F; Binder B R
Comparison of fibrinolytic activities of human and bovine endothelial cells.
The American journal of physiology 1988;254(6 Pt 2):R885-90.
1988: Wojta J; Kirchheimer J C; Peska M G; Binder B R
Effect of caffein ingestion on plasma fibrinolytic potential.
Thrombosis and haemostasis 1988;59(2):337-8.
1988: Ehrenreich F; Hattey E; Wojta J; Binder B R
Effect of anti plasminogen monoclonal antibodies on whole blood clot lysis.
Haemostasis 1988;18 Suppl 1():99-107.
1987: Kirchheimer J C; Wojta J; Hienert G; Christ G; Heger M E; Pflüger H; Binder B R
Effect of urokinase on the proliferation of primary cultures of human prostatic cells.
Thrombosis research 1987;48(3):291-8.
1987: Speiser W; Wojta J; Korninger C; Kirchheimer J C; Zazgornik J; Binder B R
Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis.
Kidney international 1987;32(2):280-3.
1987: Kirchheimer J C; Wojta J; Christ G; Binder B R
Proliferation of a human epidermal tumor cell line stimulated by urokinase.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1987;1(2):125-8.
1987: Kirchheimer J C; Resch I; Christ G; Wojta J; Binder B R
Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator.
European journal of biochemistry / FEBS 1987;166(2):393-7.
1987: Wojta J; Turcu L; Wagner O F; Korninger C; Binder B R
Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
The Journal of laboratory and clinical medicine 1987;109(6):665-71.
1987: Hattey E; Wojta J; Binder B R
Monoclonal antibodies against plasminogen and alpha-2-antiplasmin: binding to native and modified antigens.
Thrombosis research 1987;45(5):485-95.
1986: Wojta J; Kirchheimer J C; Turcu L; Christ G; Binder B R
Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
Thrombosis and haemostasis 1986;55(3):347-51.
1986: Korninger C; Speiser W; Wojta J; Binder B R
Sandwich ELISA for t-PA antigen employing a monoclonal antibody.
Thrombosis research 1986;41(4):527-35.
1985: Wojta J; Korninger C; Kirchheimer J; Hattey E; Turcu L; Binder B R
[Use of monoclonal antibodies in the diagnosis of fibrinolysis]
Wiener klinische Wochenschrift 1985;97(5):244-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Johann Wojta

Research Profile (preview)

Chemicals & Drugs

Anatomy

Physiology

Procedures

Concepts & Ideas

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Johann Wojta (preview)

All Publications